Replimune Receives Breakthrough Therapy Designation for RP1 and Submits BLA to FDA
Replimune Receives Breakthrough Therapy Designation for RP1 and Submits RP1 Biologics License Application to the FDA under the Accelerated Approval…
11/22/2024
Replimune Receives Breakthrough Therapy Designation for RP1 and Submits BLA to FDA
Replimune Receives Breakthrough Therapy Designation for RP1 and Submits RP1 Biologics License Application to the FDA under the Accelerated Approval…
|
11/22/2024
Meaning-Centered Psychotherapy for Cancer Patients
In this episode, we talk with Dr. William Breitbart, Chairman of the Department of Psychiatry and Behavioral Sciences at Memorial…
|
11/05/2024
Crafting Hope: Chris Krizek’s Journey from Cancer Patient to AIM Fundraiser with Wine Cork Creations
By Mara Klecker Chris Krizek spent his career as the vice president of a nonprofit foundation, raising money for hospitals…
|
|
11/04/2024
Book Suggestions for Caregivers
Supporting a loved one with melanoma can be a daunting journey. It often feels overwhelming. You are not only taking…
10/28/2024
Turn Hope into Action with AIM at Melanoma
At AIM at Melanoma, we are steadfast in our belief in the strength and resilience of our community. Whether you’re…
|
10/17/2024
In Plain English: Update on Melanoma Vaccines, 2024
By Kim Margolin, M.D., FACP, FASCO Recap and background on tumor vaccines We last visited the topic of vaccines in…
|
|
10/15/2024
Options For Stage II Melanoma: Making the Decision that’s Right For You
On behalf of AIM, Dr. Geoffrey Lim, a dermatologic surgeon at SkinMed Institute in Lone Tree, Colorado, conducted an interview…
10/10/2024
Coolibar’s Generous Donation to the AIM at Melanoma Foundation
Sun Safety for Everyone Under the Sun A Gift of Protection and Style Coolibar, a company that specializes in producing…
|
10/10/2024
Fall 2024 Newsletter
As we transition into fall, I wanted to take a moment to share some highlights from this busy spring and…
|
10/10/2024
Surviving the Spotlight: From Melanoma to Filmmaking
In this compelling episode of “Surviving the Spotlight,” we sit down with Jessica Gilstrap, a melanoma survivor and independent filmmaker,…
|
Recent Posts
Nov. 22, 2024
Replimune Receives Breakthrough Therapy Designation for RP1 and Submits BLA to FDA
Nov. 22, 2024
Meaning-Centered Psychotherapy for Cancer Patients
Nov. 05, 2024
Crafting Hope: Chris Krizek’s Journey from Cancer Patient to AIM Fundraiser with Wine Cork Creations
Nov. 04, 2024
Book Suggestions for Caregivers
Oct. 28, 2024